Analytical and Characterization Studies of Organic Chemicals, Drugs, and Drug Formulation
Abstract
During the period October 22, 2009 to October 21, 2010, the project personnel continued to perform chemical/physical analyses on bulk pharmaceutical substances and formulated drug products, and to manufacture dosage formulations of interest to the USAMRMC Drug Development Program for parasitic and infectious diseases, chemical and biological defense, etc. Specific objectives were to design, develop, validate, and apply methods to determine chemical and physical characteristics of the bulk drugs, drug products, to determine their stability under defined conditions, and to coordinate and work with subcontractors to produce an intravenous dosage form of artesunate.
Document Details
- Document Type
- Technical Report
- Publication Date
- Nov 01, 2010
- Accession Number
- ADA536829
Entities
People
- Peter Lim
Organizations
- SRI International